Global $8.2Bn Hematology Testing Market 2019-2029: Focus on Product Type, End-user, 11 Countries' Data, and Competitive Landscape -

DUBLIN--()--The "Global Hematology Testing Market: Focus on Product Type, End-User, 11 Countries' Data, and Competitive Landscape - Analysis and Forecast, 2019-2029" report has been added to's offering.

The global hematology testing market was valued to be $4.54 billion in 2018 and is anticipated to witness an impressive single-digit growth rate, to reach $8.2 billion by 2029.

Over the last decade, the energy sector has transformed drastically, primarily characterized by major technological disruptions. Power utilities have also faced constant pressures from regulatory bodies to reduce their carbon footprint and augment customer flexibility. In order to accommodate the growing requirements and meet the shareholder expectations, utilities have initiated several strategies such as rollout of dynamic pricing for reducing peak-load, large-scale investments in distributed generation systems, and improvements in grid balancing through demand response management.

Blockchains are essentially immutable digital ledgers that can be used to securely record all transactions taking place on a given network - once data is sealed within a block it cannot be changed retroactively. This includes not only financial transaction data, but almost anything of value.

The technology is enabling decentralized communication and co-ordination, by building the infrastructure to allow peers to safely, cheaply, and quickly connect with each other without a centralized intermediary. Cryptography ensures security and data integrity, while privacy remains intact. An economic incentive framework, also known as a consensus mechanism, allows for the peer-to-peer validation of transactions through improved security, better data management, and increased ability to co-operate among multiple actors, while bypassing the need for a trusted, centralized intermediary to verify transactions.

The rising demand for power generation from renewable sources of energy across the globe has propelled the need for increasing usage of blockchain. Moreover, there is an essential concern for decentralized power generators in the electricity distribution supply chain to reduce the electricity demand. In regions such as North America and Europe, there is huge availability of renewable energy. As a result, the blockchain market is expected to grow exponentially. The blockchain in energy market in the Asia-Pacific region is anticipated to display huge growth prospects supported by innovative technological advancements in the energy industry and increasing demand for electricity.

Key Companies of the Global Hematology Testing Industry

The key players contributing to the global hematology testing market are Abbott Laboratories, Agilent Technologies, Bio-Rad Laboratories, Inc., Boule Diagnostics AB, Danaher Corporation, Drew Scientific, EKF Diagnostics, F. Hoffmann-La Roche Ltd, HORIBA, Ltd., Mindray Medical International Limited, Nihon Kohden Corporation, Siemens Healthineers, Sysmex Corporation, Thermo Fisher Scientific Inc, and Transasia Bio-Medicals Ltd.

Key Topics Covered

Executive Summary

1 Product Definition

2 Scope of the Work

2.1 Overview: Report Scope

2.2 Segmentation of the Global Hematology Testing Market

2.3 Assumptions and Limitations

2.4 Key Questions Answered in the Report

2.5 Base Year and Forecast Period

3 Research Methodology

3.1 Overview: Report Methodology

4 Global Hematology Testing Market

4.1 Market Overview

4.2 Introduction to Hematology

4.3 Importance of Hematology Testing

4.4 Market Dynamics

4.5 Global Market Scenario

4.6 Assumptions and Limitations

5 Competitive Landscape

5.1 Overview

5.2 Key Developments and Strategies

5.2.1 Product Launch and Development

5.2.2 Product Approvals and Certifications

5.2.3 Collaborations, Partnerships, and Joint Ventures

5.2.4 Business Expansions and Acquisitions

5.2.5 Others

5.3 Market Share Analysis

6 Industry Insights

6.1 Validation of Hematology Systems

6.2 Regulatory Scenario

6.3 Key Industry Insight

6.3.1 Paradigm Shift toward Putting Hematology Analyzers on Lease instead of Sale

7 Global Hematology Testing Market (by Product)

7.1 Overview

7.2 Instruments and Software

7.2.1 Hematology Analyzer and Software

7.2.2 Image Analyzer and Cell Counter

7.2.3 Flow Cytometer

7.2.4 Others

7.3 Consumables

7.3.1 Hematology Reagents

7.3.2 Flow Cytometry Reagents

7.3.3 Stains, Controls, and Calibrators

8 Global Hematology Testing Market (by End User)

8.1 Overview

8.2 Hospitals

8.3 Clinical Testing Laboratories

8.4 Research Institutes

8.5 Patient Self-Testing

8.6 Others

9 Global Hematology Testing Market (by Region)

9.1 Overview

9.2 North America

9.2.1 Overview

9.2.2 U.S.

9.2.3 Canada

9.3 Europe

9.3.1 Overview

9.3.2 Germany

9.3.3 U.K.

9.3.4 France

9.3.5 Italy

9.3.6 Rest-of-Europe

9.4 Asia-Pacific

9.4.1 Overview

9.4.2 Japan

9.4.3 China

9.4.4 India

9.4.5 Australia

9.4.6 South Korea

9.4.7 Rest-of-Asia-Pacific

9.5 Rest-of-the-World

9.5.1 Overview

10 Company Profiles

10.1 Overview

10.2 Abbott Laboratories

10.2.1 Company Overview

10.2.2 Role of Abbott Laboratories in the Global Hematology Testing Market

10.2.3 Financials

10.2.4 SWOT Analysis

10.3 Agilent Technologies, Inc.

10.4 Bio-Rad Laboratories, Inc.

10.5 Boule Diagnostics AB

10.6 Danaher Corporation

10.7 Drew Scientific Inc.

10.8 EKF Diagnostics Holdings plc

10.9 F. Hoffmann-La Roche Ltd

10.10 HORIBA, Ltd.

10.11 Mindray Medical International Limited

10.12 Nihon Kohden Corporation

10.13 Siemens Healthineers AG

10.14 Sysmex Corporation

10.15 Thermo Fisher Scientific Inc.

10.16 Transasia Bio-Medicals Ltd.

For more information about this report visit

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Laura Wood, Senior Press Manager
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900